Homepage
Catalog of Screening Compounds Screening Libraries Focused and Target Libraries Active Reference Sets Diversity Libraries
Screening Compounds Building blocks
Drug Discovery Services Custom Chemistry Medicinal chemistry In silico Drug Design (CADD) Discovery Biology Animal Models Toxicology and Safety ADME, DMPK Chemistry, Manufacturing and Controls
Company News & Media Contact us For suppliers Trends in discovery compounds
Homepage > Company > Media > Pharma News

Pharma News

Dr. Reddy’s launches Wellbutrin XL, Skelaxin generics
Dr. Reddy’s launches Wellbutrin XL, Skelaxin generics
HYDERABAD, India, and PRINCETON, N.
Tezepelumab Significantly Reduced Asthma Exacerbations For A Broad Population Of Patients With Severe Uncontrolled Asthma
Tezepelumab Significantly Reduced Asthma Exacerbations For A Broad Population Of Patients With Severe Uncontrolled Asthma
THOUSAND OAKS, Calif.
Lilly to lay off 8 percent of employees in bid to cut costs
Lilly to lay off 8 percent of employees in bid to cut costs
(Reuters) - Eli Lilly and Co (LLY.
Novo Nordisk resolves US federal investigation into marketing practices
Novo Nordisk resolves US federal investigation into marketing practices
Novo Nordisk has said it has reached a resolution with the US federal government and the states about an investigation launched in February 2011 concerning sales and marketing practices for Victoza, i...
Akcea and Ionis Announce Submission of New Drug Application for Volanesorsen to the U.S. FDA
Akcea and Ionis Announce Submission of New Drug Application for Volanesorsen to the U.S. FDA
CAMBRIDGE, Mass.
Merck to Acquire Rigontec, RIG-I Therapeutics Pioneer, Advancing Leadership in Immuno-Oncology
Merck to Acquire Rigontec, RIG-I Therapeutics Pioneer, Advancing Leadership in Immuno-Oncology
KENILWORTH, N.
Bioverativ and Bicycle Therapeutics team up in haemophilia
Bioverativ and Bicycle Therapeutics team up in haemophilia
Bioverativ and Bicycle Therapeutics have announced a research collaboration focused on the discovery, development and commercialisation of innovative therapies for haemophilia and sickle cell disease.
FDA approves Chemo Research's treatment for Chagas disease
FDA approves Chemo Research's treatment for Chagas disease
WASHINGTON — Earlier this week the U.
Gilead to acquire Kite Pharma
Gilead to acquire Kite Pharma
FOSTER CITY and SANTA MONICA, Calif.
Merck KGaA, Darmstadt, Germany, Prepares Strategic Options for the Consumer Health Business
Merck KGaA, Darmstadt, Germany, Prepares Strategic Options for the Consumer Health Business
Darmstadt, Germany, September 5, 2017 – Merck KGaA, Darmstadt, Germany, is preparing strategic options for its Consumer Health business, including a potential full or partial sale of the business as...
Yemen's cholera epidemic hits 600,000, confounding expectations
Yemen's cholera epidemic hits 600,000, confounding expectations
GENEVA (Reuters) - Yemen’s cholera outbreak has infected 612,703 people and killed 2,048 since it began in April, and some districts are still reporting sharp rises in new cases, data from t...
Fujifilm outlines its ambitions in healthcare
Fujifilm outlines its ambitions in healthcare
Japanese conglomerate Fujifilm Holdings (TYO.
Catalog of Screening Compounds Screening Libraries Screening Compounds Building blocks
Drug Discovery Services News & Media Contact us
Payment systems
Policies & Terms     ©2023 ChemDiv     ChemistryOnDemand